(Q35903203)

11 August 2017

1 reference

title

Update on herpesvirus amplicon vectors (English)

1 reference

11 August 2017

1 reference

Xandra O. Breakefield

series ordinal

3

object named as

Xandra O Breakefield

1 reference

11 August 2017

Angelika Oehmig

1

1 reference

PubMed ID

15451447

11 August 2017

Cornel Fraefel

series ordinal

2

1 reference

11 August 2017

1 October 2004

1 reference

11 August 2017

1 reference

11 August 2017

10

1 reference

11 August 2017

4

1 reference

11 August 2017

630-643

1 reference

Herpes simplex virus type 1-based amplicon vector systems

11 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

HSV-1 amplicon vectors--simplicity and versatility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Gene transfer into neurones for the molecular analysis of behaviour: focus on herpes simplex vectors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Gene delivery using herpes simplex virus vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

The alpha promoter regulator-ovalbumin chimeric gene resident in human cells is regulated like the authentic alpha 4 gene after infection with herpes simplex virus 1 mutants in alpha 4 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Replication-defective genomic herpes simplex vectors: design and production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Viral therapy for glioblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Varicella-zoster virus infection of a human CD4-positive T-cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Rescue of human cytomegalovirus strain AD169 tropism for both leukocytes and human endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Human herpesvirus 6: molecular biology and clinical features.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Human herpesvirus 8 interaction with target cells involves heparan sulfate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Structure of the herpes simplex virus capsid: peptide A862-H880 of the major capsid protein is displayed on the rim of the capsomer protrusions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Incorporation of green fluorescent protein into the essential envelope glycoprotein B of herpes simplex virus type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

A single amino acid substitution in herpes simplex virus type 1 VP16 inhibits binding to the virion host shutoff protein and is incompatible with virus growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Retrograde axonal transport of herpes simplex virus: evidence for a single mechanism and a role for tegument

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Intercellular trafficking and protein delivery by a herpesvirus structural protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

VP22 enhanced intercellular trafficking of HSV thymidine kinase reduced the level of ganciclovir needed to cause suicide cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Intratumoral spread and increased efficacy of a p53-VP22 fusion protein expressed by a recombinant adenovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Enhanced suicide gene effect by adenoviral transduction of a VP22-cytosine deaminase (CD) fusion gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Of the three tegument proteins that package mRNA in herpes simplex virions, one (VP22) transports the mRNA to uninfected cells for expression prior to viral infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

The virion host shutoff function of herpes simplex virus degrades the 5' end of a target mRNA before the 3' end.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

RNAs extracted from herpes simplex virus 1 virions: apparent selectivity of viral but not cellular RNAs packaged in virions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

The herpes simplex virus amplicon: A new eucaryotic defective-virus cloning-amplifying vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

The herpes simplex virus amplicon: analyses of cis-acting replication functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Reporter gene transfer induces apoptosis in primary cortical neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Deletion of multiple immediate-early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Helper-free HSV-1 amplicons elicit a markedly less robust innate immune response in the CNS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Genetic engineering of herpes simplex virus and vector genomes carrying loxP sites in cells expressing Cre recombinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

A novel approach for herpes simplex virus type 1 amplicon vector production, using the Cre-loxP recombination system to remove helper virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Improved packaging system for generation of high-level noncytotoxic HSV-1 amplicon vectors using Cre-loxP site-specific recombination to delete the packaging signals of defective helper genomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

A cosmid-based system for constructing mutants of herpes simplex virus type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Herpes simplex virus type 1 DNA amplified as bacterial artificial chromosome in Escherichia coli: rescue of replication-competent virus progeny and packaging of amplicon vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Allele replacement: an application that permits rapid manipulation of herpes simplex virus type 1 genomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Cloning and stable maintenance of 300-kilobase-pair fragments of human DNA in Escherichia coli using an F-factor-based vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Improved titers for helper virus-free herpes simplex virus type 1 plasmid vectors by optimization of the packaging protocol and addition of noninfectious herpes simplex virus-related particles (previral DNA replication enveloped particles) to the pa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Expression of vhs and VP16 during HSV-1 helper virus-free amplicon packaging enhances titers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Enhanced reporter gene expression in the rat brain from helper virus-free HSV-1 vectors packaged in the presence of specific mutated HSV-1 proteins that affect the virion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Prolonged in vivo gene expression driven by a tyrosine hydroxylase promoter in a defective herpes simplex virus amplicon vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Preproenkephalin promoter yields region-specific and long-term expression in adult brain after direct in vivo gene transfer via a defective herpes simplex viral vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

HSV-1 infected cell proteins influence tetracycline-regulated transgene expression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Human cytomegalovirus infection of human hematopoietic progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Cloning and mutagenesis of a herpesvirus genome as an infectious bacterial artificial chromosome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Construction of a cytomegalovirus-based amplicon: a vector with a unique transfer capacity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Identification and characterization of oriLyt, a lytic origin of DNA replication of Epstein-Barr virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

A first-generation packaging cell line for Epstein-Barr virus-derived vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Infectious delivery of 120-kilobase genomic DNA by an epstein-barr virus amplicon vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Use of amplicon-6 vectors derived from human herpesvirus 6 for efficient expression of membrane-associated and -secreted proteins in T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Development of new expression vector based on Pseudorabies virus amplicons: application to human insulin expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Exploiting circuit-specific spread of pseudorabies virus in the central nervous system: insights to pathogenesis and circuit tracers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

A herpesvirus saimiri-based gene therapy vector with potential for use in cancer immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

A cell surface protein with herpesvirus entry activity (HveB) confers susceptibility to infection by mutants of herpes simplex virus type 1, herpes simplex virus type 2, and pseudorabies virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Nectin-3, a new member of immunoglobulin-like cell adhesion molecules that shows homophilic and heterophilic cell-cell adhesion activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Microtubule-mediated transport of incoming herpes simplex virus 1 capsids to the nucleus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Herpes simplex virus glycoprotein D is sufficient to induce spontaneous pH-independent fusion in a cell line that constitutively expresses the glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Pseudotyping of glycoprotein D-deficient herpes simplex virus type 1 with vesicular stomatitis virus glycoprotein G enables mutant virus attachment and entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

HSV-1 amplicon peptide display vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

HSV-1 virions engineered for specific binding to cell surface receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Herpes simplex viral and amplicon vector-mediated gene transfer into glia and neurons in organotypic spinal cord and dorsal root ganglion cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Highly efficient and specific gene transfer to Purkinje cells in vivo using a herpes simplex virus I amplicon.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Gene transfer to the nigrostriatal system by hybrid herpes simplex virus/adeno-associated virus amplicon vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

FGF-2 regulates neurogenesis and degeneration in the dentate gyrus after traumatic brain injury in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Chronic Neurotrophin-3 Strengthens Synaptic Connections to Motoneurons in the Neonatal Rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Green fluorescent protein as a reporter for retrovirus and helper virus-free HSV-1 amplicon vector-mediated gene transfer into neural cells in culture and in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Modified herpes simplex virus delivery of enhanced GFP into the central nervous system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Topical application of viral vectors for epidermal gene transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Dendritic cells transduced with HSV-1 amplicons expressing prostate-specific antigen generate antitumor immunity in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Neurotrophin-3 transduction attenuates cisplatin spiral ganglion neuron ototoxicity in the cochlea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Gene transfer into the mammalian inner ear using HSV-1 and vaccinia virus vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

In vivo imaging of HIV protease activity in amplicon vector-transduced gliomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Herpes simplex virus type 1 amplicon vector-mediated gene transfer to muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

HSV/AAV hybrid amplicon vectors extend transgene expression in human glioma cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Herpes simplex virus type 1/adeno-associated virus hybrid vectors mediate site-specific integration at the adeno-associated virus preintegration site, AAVS1, on human chromosome 19.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Herpes simplex virus type 1/adeno-associated virus rep(+) hybrid amplicon vector improves the stability of transgene expression in human cells by site-specific integration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Roles of adeno-associated virus Rep protein and human chromosome 19 in site-specific recombination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Targeted transgene integration into transgenic mouse fibroblasts carrying the full-length human AAVS1 locus mediated by HSV/AAV rep(+) hybrid amplicon vector.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

An infectious transfer and expression system for genomic DNA loci in human and mouse cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Infectious delivery of a 135-kb LDLR genomic locus leads to regulated complementation of low-density lipoprotein receptor deficiency in human cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Generation of stable retrovirus packaging cell lines after transduction with herpes simplex virus hybrid amplicon vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Potentiated gene delivery to tumors using herpes simplex virus/Epstein-Barr virus/RV tribrid amplicon vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Hypoxia-inducible factor-1alpha mediates hypoxia-induced delayed neuronal death that involves p53.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Herpes simplex virus type 1 amplicon vectors with glucocorticoid-inducible gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Regulation of endogenous gene expression with a small-molecule dimerizer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Dimerizer-regulated gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Single HSV-amplicon vector mediates drug-induced gene expression via dimerizer system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

A tetracycline controlled activation/repression system with increased potential for gene transfer into mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Perinuclear biogenesis of mutant torsin-A inclusions in cultured cells infected with tetracycline-regulated herpes simplex virus type 1 amplicon vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Rapid in vivo isolation of gene expression elements using an HSV amplicon system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

High-titer recombinant adeno-associated virus production from replicating amplicons and herpes vectors deleted for glycoprotein H.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Optimization of recombinant adeno-associated virus production using an herpes simplex virus amplicon system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

An HSV amplicon-based helper system for helper-dependent adenoviral vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Measuring transferrin receptor gene expression by NMR imaging.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Iron-responsive elements: regulatory RNA sequences that control mRNA levels and translation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Overexpression of iron-responsive element-binding protein and its analytical characterization as the RNA-binding form, devoid of an iron-sulfur cluster

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

In vivo magnetic resonance imaging of transgene expression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

MRI of transgene expression: correlation to therapeutic gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

APO2 ligand: a novel lethal weapon against malignant glioma?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

In vivo measurement of gene expression, angiogenesis and physiological function in tumors using multiphoton laser scanning microscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

A novel method for imaging apoptosis using a caspase-1 near-infrared fluorescent probe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Infections with herpes simplex viruses (2).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Pre-existing herpes simplex virus 1 (HSV-1) immunity decreases, but does not abolish, gene transfer to experimental brain tumors by a HSV-1 vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Effect of prior exposure to herpes simplex virus 1 on viral vector-mediated tumor therapy in immunocompetent mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Immune responses to replication-defective HSV-1 type vectors within the CNS: implications for gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Tumor growth inhibition by intratumoral inoculation of defective herpes simplex virus vectors expressing granulocyte-macrophage colony-stimulating factor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Helper virus-free herpes simplex virus type 1 amplicon vectors for granulocyte-macrophage colony-stimulating factor-enhanced vaccination therapy for experimental glioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Development of herpes simplex virus-1 amplicon-based immunotherapy for chronic lymphocytic leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

HSV amplicon-mediated delivery of LIGHT enhances the antigen-presenting capacity of chronic lymphocytic leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Expression of human immunodeficiency virus type 1 gp120 from herpes simplex virus type 1-derived amplicons results in potent, specific, and durable cellular and humoral immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Cellular immune responses to helper-free HSV-1 amplicon particles encoding HIV-1 gp120 are enhanced by DNA priming

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Real-time imaging of TRAIL-induced apoptosis of glioma tumors in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

Recombinant adeno-associated virus type 2 replication and packaging is entirely supported by a herpes simplex virus type 1 amplicon expressing Rep and Cap

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

An 85-kilodalton herpes simplex virus type 1 alpha trans-induction factor (VP16)-VP13/14 fusion protein retains the transactivation and structural properties of the wild-type molecule during virus infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

7 January 2021

The virion host shutoff protein of herpes simplex virus type 1: messenger ribonucleolytic activity in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

7 January 2021

An enhanced packaging system for helper-dependent herpes simplex virus vectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

7 January 2021

Cytotoxicity of a replication-defective mutant of herpes simplex virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

7 January 2021

Tamplicon-7, a novel T-lymphotropic vector derived from human herpesvirus 7

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

7 January 2021

Initial interaction of herpes simplex virus with cells is binding to heparan sulfate

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

7 January 2021

Recombinant herpes simplex virus type 1 engineered for targeted binding to erythropoietin receptor-bearing cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

7 January 2021

Development of animal models for adeno-associated virus site-specific integration

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.641

7 January 2021

10.1016/J.YMTHE.2004.06.641

Identifiers

DOI

1 reference

release_q5adtvq3anf4jek3efmbox5r7m

11 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/q5adtvq3anf4jek3efmbox5r7m

24 November 2022

mapped directly with Wikidata item

PubMed ID

15451447

1 reference

PubMed ID

15451447